Back

Discussant review - KARDIA-3

30 August 2025 (16:40 - 16:43)
Organised by: Logo
Congress Presentation Part of: HOT LINE 4 Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Maciej Tomaszewski

University of Manchester, Manchester (United Kingdom of Great Britain & Northern Ireland)

11 More presentations in this session

Presentation thumbnail
BaxHTN – Efficacy and safety of the aldosterone synthase inhibitor baxdrostat in patients with uncontrolled or resistant hypertension
Professor B. Williams (London, GB)
Slides Video
Presentation thumbnail
Discussant review - BaxHTN
Professor T. Guzik (Edinburgh, GB)
Slides Video
Presentation thumbnail
Panel discussion - BaxHTN
Presentation thumbnail
KARDIA-3: Zilebesiran as Add-on Therapy in Adults with Hypertension and Established Cardiovascular Disease or at High Cardiovascular Risk
Doctor N. Pagidipati (Durham, US)
Slides Video
Presentation thumbnail
Panel discussion - KARDIA-3
Video

Access the full session

Session thumbnail
HOT LINE 4
Video

The Event

Event poster

ESC Congress 2025

30 August 2025 16:40 CET
You may be interested in
thumbnail
Congress Presentation
KARDIA-3: Zilebesiran as Add-on Therapy in Adults with Hypertension and Established Cardiovascular Disease or at High Cardiovascular Risk
thumbnail
Congress Session
HOT LINE 4
thumbnail
Congress Presentation
Subgroup results from KARDIA-2: impact of demographic and baseline disease characteristics on zilebesiran response in patients with hypertension uncontrolled by a standard oral antihypertensive

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources